BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34428232)

  • 1. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.
    Das VNR; Siddiqui NA; Bhunia GS; Pandey K; Sinha SK; Ansari MZ; Topno RK; Lal CS; Ranjan A; Singh VP; Das P
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009598. PubMed ID: 34428232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programme.
    Siddiqui NA; Pandey K; R Das VN; Sinha SK; Verma RB; Lal CS; Ali V; Topno RK; Dikhit MR; Das P
    J Vector Borne Dis; 2019; 56(4):315-322. PubMed ID: 33269731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing clinico-epidemiology of post-kala-azar dermal leishmaniasis (PKDL) in India: Results of a survey in four endemic states.
    Saurabh S; Roy P; Pandey DK; Ray D; Tarak S; Pandey R; Kumar D; Jamil S; Paulraj A; Kumar A; Dutta S
    J Vector Borne Dis; 2020; 57(2):161-169. PubMed ID: 34290161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site.
    Hasker E; Malaviya P; Scholar VK; de Koning P; Singh OP; Kansal S; Cloots K; Boelaert M; Sundar S
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007798. PubMed ID: 31652262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India.
    Goyal V; Das VNR; Singh SN; Singh RS; Pandey K; Verma N; Hightower A; Rijal S; Das P; Alvar J; Bern C; Alves F
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008429. PubMed ID: 32687498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of trained field workers in diagnosis of post-kala-azar dermal leishmaniasis (PKDL) and clinico-epidemiological profile in highly endemic areas of Bihar.
    Das VNR; Siddiqui NA; Pandey K; Lal CS; Sinha SK; Bimal S; Topno RK; Singh SK; Kumar S; Das P
    Trans R Soc Trop Med Hyg; 2019 Jun; 113(6):332-340. PubMed ID: 30920625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kala-azar elimination in a highly-endemic district of Bihar, India: A success story.
    Kumar V; Mandal R; Das S; Kesari S; Dinesh DS; Pandey K; Das VR; Topno RK; Sharma MP; Dasgupta RK; Das P
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008254. PubMed ID: 32365060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased
    Cloots K; Marino P; Burza S; Gill N; Boelaert M; Hasker E
    Front Cell Infect Microbiol; 2021; 11():604117. PubMed ID: 33777831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Post-Kala-azar Dermal Leishmaniasis.
    Ghosh P; Roy P; Chaudhuri SJ; Das NK
    Indian J Dermatol; 2021; 66(1):12-23. PubMed ID: 33911289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensely clustered outbreak of visceral leishmaniasis (kala-azar) in a setting of seasonal migration in a village of Bihar, India.
    Kumar A; Saurabh S; Jamil S; Kumar V
    BMC Infect Dis; 2020 Jan; 20(1):10. PubMed ID: 31906924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
    Kumar A; Singh VK; Tiwari R; Madhukar P; Rajneesh ; Kumar S; Gautam V; Engwerda C; Sundar S; Kumar R
    Front Immunol; 2023; 14():1236952. PubMed ID: 37638047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of non-invasive samples and tools in kala-azar diagnosis and test of cure.
    Vijayakumar S; Narayan PK; Kumari S; Ranjan R; Kumar V; Kumar A; Alti D
    Exp Parasitol; 2024 Apr; 259():108713. PubMed ID: 38350522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time for a village-level strategy for the elimination of kala-azar (visceral leishmaniasis) in India: analysis of potential kala-azar outbreak situation in 2018.
    Saurabh S
    Trop Doct; 2021 Jan; 51(1):84-91. PubMed ID: 32903147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal.
    Joshi AB; Banjara MR; Das ML; Ghale P; Pant KR; Parajuli N; Pyakurel UR; Dahal GR; Das CL; Kroeger A; Aseffa A
    PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011138. PubMed ID: 36758102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
    Chapman LAC; Spencer SEF; Pollington TM; Jewell CP; Mondal D; Alvar J; Hollingsworth TD; Cameron MM; Bern C; Medley GF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25742-25750. PubMed ID: 32973088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active surveillance identified a neglected burden of macular cases of Post Kala-azar Dermal Leishmaniasis in West Bengal.
    Sengupta R; Chaudhuri SJ; Moulik S; Ghosh MK; Saha B; Das NK; Chatterjee M
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007249. PubMed ID: 30856178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
    Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study.
    Singh OP; Tiwary P; Kushwaha AK; Singh SK; Singh DK; Lawyer P; Rowton E; Chaubey R; Singh AK; Rai TK; Fay MP; Chakravarty J; Sacks D; Sundar S
    Lancet Microbe; 2021 Jan; 2(1):e23-e31. PubMed ID: 33615281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery.
    Hasan MM; Proma SB; Hossain MS; Arifuzzaman M; Islam N; Siddique MAB; Amiruzzaman
    BMC Infect Dis; 2023 Dec; 23(1):885. PubMed ID: 38110894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling spatiotemporal patterns of visceral leishmaniasis incidence in two endemic states in India using environment, bioclimatic and demographic data, 2013-2022.
    Subramanian S; Maheswari RU; Prabavathy G; Khan MA; Brindha B; Srividya A; Kumar A; Rahi M; Nightingale ES; Medley GF; Cameron MM; Roy N; Jambulingam P
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011946. PubMed ID: 38315725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.